Inotek Pharmaceuticals Corp (ITEK): Great Point Partners Adds to Its Position

Page 3 of 10

Page 3 of 10 – SEC Filing
CUSIP No.  45780V102 13G Page 3 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Dr. Jeffrey R. Jay, M.D.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)

[_]

(b)

[_]

3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

1,366,500

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

1,366,500

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,366,500

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
(See Instructions)

[_]

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.07%1

12.

TYPE OF REPORTING PERSON (See Instructions)

IN

Follow Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Page 3 of 10